2005Expert Opinion on PharmacotherapyRequires access

Pregabalin or morphine and gabapentin for neuropathic pain

Sheila Anne Doggrell

Open publisher page 8 citations

Abstract

Common causes of neuropathic pain are diabetes and herpes zoster, with 15% of patients with long-standing diabetes and 11% of herpes patients suffering from this pain. Gabapentin and pregabalin modulate the α2δ calcium-channel subunits, possibly decreasing the neurotransmitter release associated with the central sensitisation that occurs in neuropathic pain. Gabapentin has been shown to be effective in neuropathic pain and, recently, so has pregabalin. These agents seem to have similar efficacy when used alone, but this needs to be tested in a head-to-head trial. A clinical trial comparing morphine, gabapentin or their combination at lower doses showed that the combination of morphine and gabapentin reduced the pain score to a greater extent than either agent alone. This combination treatment represents a novel approach to neuropathic pain.

About this research paper

What this paper is about

Common causes of neuropathic pain are diabetes and herpes zoster, with 15% of patients with long-standing diabetes and 11% of herpes patients suffering from this pain. Gabapentin and pregabalin modulate the α2δ calcium-channel subunits, possibly decreasing the neurotransmitter release associated with the central sensitisation that occurs in neuropathic pain. Gabapentin has been shown to be effective in neuropathic pain and, recently, so has pregabalin. These agents seem to have similar efficacy when used alone, but this needs to be tested in a head-to-head trial. A clinical trial comparing morphine, gabapentin or their combination at lower doses showed that the combination of morphine and gabapentin reduced the pain score to a greater extent than either agent alone. This combination treatment represents a novel approach to neuropathic pain.

Why it matters

OpenAlex reports 8 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Common causes of neuropathic pain are diabetes and herpes zoster, with 15% of patients with long-standing diabetes and 11% of herpes patients suffering from this pain. Gabapentin and pregabalin modulate the α2δ calcium-channel subunits, possibly decreasing the neurotransmitter release associated with the central sensitisation that occurs in neuropathic pain. Gabapentin has been shown to be effective in neuropathic pain and, recently, so has pregabalin. These agents seem to have similar efficacy when used alone, but this needs to be tested in a head-to-head trial. A clinical trial comparing morphine, gabapentin or their combination at lower doses showed that the combination of morphine and gabapentin reduced the pain score to a greater extent than either agent alone. This combination treatment represents a novel approach to neuropathic pain.

Key concepts: Gabapentin, Pregabalin, Neuropathic pain, Medicine, Morphine, Anesthesia, Pharmacology, Pathology

Related papers

Back to paper searchBrowse research topicsOriginal source
Pregabalin or morphine and gabapentin for neuropathic pain — Research Paper | ScholarLens